NCT02554695View on ClinicalTrials.gov

Osteoclast Inhibition and Bone Formation

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

81

Participants

Timeline

Start Date

October 20, 2015

Primary Completion Date

October 25, 2016

Study Completion Date

October 25, 2016

Conditions

Bone LossAging

Interventions

DRUG

placebo

subcutaneous saline injection

DRUG

denosumab

single subcutaneous injection of denosumab 60 mg

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER